Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IOB Institute of Oncology is a Spain-based oncology care organization focused on the diagnosis, prevention, treatment, and clinical investigation of cancer and hematologic malignancies. Founded by Dr. Josep Baselga and Dr. Josep Tabernero, the group operates as a multidisciplinary cancer institute with strong capabilities in precision oncology and clinical trials. IOB works in close association with Quirónsalud hospitals in Barcelona and Madrid and provides specialist disease-unit care across breast, gastrointestinal, lung, head and neck, genitourinary, gynecologic, and hemato-oncology. Rather than a drug-development biotech company with a proprietary therapeutic pipeline, IOB is best understood as an oncology provider and research center offering patient care, advanced diagnostics, and access to investigational therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IOB Institute of Oncology.